172 related articles for article (PubMed ID: 35177765)
1. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells.
Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J
Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588
[TBL] [Abstract][Full Text] [Related]
3. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
5. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
7. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Li J; Yue H; Yu H; Lu X; Xue X
BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide N-methyltransferase expression and its association with phospho-Akt, p53 expression, and survival in high-grade endometrial cancer.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Turk J Med Sci; 2019 Oct; 49(5):1547-1554. PubMed ID: 31652035
[TBL] [Abstract][Full Text] [Related]
10. Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.
Li J; You S; Zhang S; Hu Q; Wang F; Chi X; Zhao W; Xie C; Zhang C; Yu Y; Liu J; Zhao Y; Liu P; Zhang Y; Wei X; Li Q; Wang X; Yin Z
Mol Oncol; 2019 Sep; 13(9):1993-2009. PubMed ID: 31294922
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase expression in SH-SY5Y human neuroblastoma cells decreases oxidative stress.
Mistry RJ; Klamt F; Ramsden DB; Parsons RB
J Biochem Mol Toxicol; 2020 Mar; 34(3):e22439. PubMed ID: 31909875
[TBL] [Abstract][Full Text] [Related]
15. Expression and Clinical Significance of Nicotinamide N-Methyltransferase in Cervical Squamous Cell Carcinoma.
Akar S; Harmankaya İ; Uğraş S; Çelik Ç
Int J Gynecol Pathol; 2020 May; 39(3):289-295. PubMed ID: 31033801
[TBL] [Abstract][Full Text] [Related]
16. Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells.
Tomida M; Ohtake H; Yokota T; Kobayashi Y; Kurosumi M
J Cancer Res Clin Oncol; 2008 May; 134(5):551-9. PubMed ID: 17922140
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.
Tomida M; Mikami I; Takeuchi S; Nishimura H; Akiyama H
J Cancer Res Clin Oncol; 2009 Sep; 135(9):1223-9. PubMed ID: 19242722
[TBL] [Abstract][Full Text] [Related]
18. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer.
Liu W; Zhu M; Li X; Er L; Li S
Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086
[TBL] [Abstract][Full Text] [Related]
19. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
20. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
